This single-center study evaluates a two-stage, lymph-sparing ultrasound-assisted liposuction (VASER-UAL) protocol in 191 women (stage 1-3 lipedema) refractory to six months of conservative therapy. Twelve-month follow-up showed a mean circumference reduction of 6.4 cm across all limb regions, accompanied by marked declines in pain, bruising, and tactile hypersensitivity. No postoperative phlebitis and only routine minor complications were reported, underscoring the safety of the technique. The large cohort and stringent outcome set advance evidence that next-generation UAL can debulk pathologic adipose tissue while protecting lymphatics, positioning surgery as a definitive, durable option within a multidisciplinary pathway for lipedema care.:contentReference[oaicite:0]{index=0}
Authors & affiliations
Barbara Hersant Henri Mondor Hospital, Créteil, France; Eloi de Clermont-Tonnerre Henri Mondor Hospital, France; Giulia Argentino Henri Mondor Hospital, France; Malika Bensid Henri Mondor Hospital, France; Said Bensaid Henri Mondor Hospital, France; Gioanni Roccaro Henri Mondor Hospital, France; Oana Hermeziu Henri Mondor Hospital, France; Andrea Murante Università di Napoli “Federico II”, Italy; Simone La Padula Università di Napoli “Federico II”, Italy; Jean Paul Meningaud Henri Mondor Hospital, France
Tags: Aesthetic surgery – lower limb; Lipedema; Subcutaneous fat removal – Liposuction – Females.; UAL-Ultrasound-assisted liposuction; liposuction.
